Page 5 - Restricted Use News Today

The Drugs Controller General of India (DCGI) on Tuesday approved three Covid vaccines for the restricted emergency use authorisation (EUA) for children of different age groups.

Covaxin for 6-12 age group, Corbevax for 5-12 and two doses ZyCoV-D for above 12 years

/PRNewswire/ -- The "Diagnostic Specialty Antibodies Market by Type, Clonality, Technique, Conjugate, and Application - Forecast to 2029" report has been added...

More than a dozen charity hospitals in northwest Syria have shut down or downsized their capacity due to funding cuts.

Houthi attack jeopardises the UAE’s reputation as a haven for tourism and trade and pushes it towards caution with Iran.

The Central government is examining the recommendation of the Subject Expert Committee (SEC) regarding the grant of market authorization of Covaxin for the age group of 2 to 18 years for restricted use in an emergency situation subject to various conditions, Ministry of Health and Family Welfare (MoHF) told Rajya Sabha on Tuesday.

The Interim Phase II, III clinical trial data of COVAXIN on Healthy Volunteers aged 2 to 18 years submitted by Bharat Biotech was deliberated in the meeting of the Subject Expert Committee (SEC) on August 28 and October 11, informed Ministry of Health and Family Welfare.

The Central government is examining the recommendation to grant market authorization to Covaxin for the age group of 2 to 18 years.

The government said it is examining Pfizers request for indemnity and will take a decision in the larger interest of people and on merit.

Pfizer told Indian authorities that its vaccine has demonstrated